• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Antios Therapeutics

Graphic of a graveyard with an orange sky and bats flying above
Biotech

The 2023 Biotech Graveyard

Nearly four times as many companies entered the biotech graveyard in 2023 compared to 2022.
Max Bayer , Gabrielle Masson Oct 31, 2023 6:00am
dominoes stop stall halt end red

Hep B biotech Antios closed after FDA hold proved insurmountable

Sep 22, 2023 11:23am
birds eye photo of a piece of machinery about to move a box on an assembly line

Assembly's line of core inhibitors wobbles on the conveyor belt

Apr 19, 2023 10:15am
pitfalls potholes trouble challenge jump avoid struggle problem

Antios hep B drug slows viral rebound, but FDA hold casts shadow

Jun 27, 2022 11:41am
FDA

Antios rocked as hepatitis B safety signal sparks clinical hold

May 25, 2022 8:42am
hepatitis B virus

Antios raises a further $75M to fuel pursuit of hepatitis B cure

Nov 3, 2021 9:15am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings